首页> 美国卫生研究院文献>Core Evidence >Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety efficacy and place in therapy

【2h】

Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety efficacy and place in therapy

机译：长春氟宁用于治疗尿路上皮的晚期或转移性移行细胞癌：基于证据的安全性有效性和治疗方法综述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundA systematic review and meta-analysis of the use of systemic vinflunine (VIN) in the treatment of urothelial carcinoma (UC) was performed to evaluate its efficacy based on current available clinical data.

机译：背景进行了系统性长春氟宁（VIN）在治疗尿路上皮癌（UC）中的应用的系统评价和荟萃分析，以根据当前可得的临床数据评估其疗效。

著录项

期刊名称 Core Evidence
作者
Steven C Brousell; Joseph J Fantony; Megan G Van Noord; Michael R Harrison; Brant A Inman;
展开▼
作者单位

展开▼
年(卷),期 2018(13),-1
年度 2018
页码 1–12
总页数 12
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
vinflunine urothelial carcinoma bladder cancer metastatic survival chemotherapy;

机译：长春氟宁;尿路上皮癌;膀胱癌;转移性;生存期;化疗;

相似文献

外文文献
中文文献
专利

1. Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy [J] . Steven C Brousell, Joseph J Fantony, Megan G Van Noord, Core Evidence . 2018,第3期

机译：长春氟宁用于治疗尿路上皮的晚期或转移性移行细胞癌：基于证据的安全性，有效性和治疗方法综述
2. Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study [J] . Jacques Médioni, Mario Di Palma, Aline Guillot, BMC Cancer . 2016,第1期

机译：根据法国多中心CURVE研究，长春氟宁对常规或晚期尿路上皮癌的疗效和安全性
3. VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland [J] . Syed A. Hussain, Jawaher Ansari, Robert Huddart, International journal of oncology . 2017,第3期

机译：维克多：长春氟宁在尿路上皮晚期转移性移行细胞癌中的应用：通过免费计划对英国和爱尔兰的患者在多中心现实生活中使用长春氟宁作为二线化疗的回顾性分析
4. Integration of Surgery and Systemic Therapy in the Treatment of Locally Advanced and Metastatic Renal Cell Carcinoma [C] . Christopher G. Wood Genitourinary Cancers Symposium . 2011

机译：外科和全身治疗在局部晚期和转移性肾细胞癌中的整合
5. Cox-2 expression-targeted gene therapy for the treatment of transitional cell carcinoma. [D] . Zhang, Xiujuan. 2010

机译：Cox-2表达靶向基因疗法用于治疗移行细胞癌。
6. Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice [O] . Daniel Castellano, Javier Puente, Guillermo de Velasco, 2014

机译：在临床实践中一种基于铂的全身疗法失败后长春氟宁在尿路转移性移行细胞癌患者中的安全性和有效性
7. Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy [O] . Steven C Brousell, Joseph J Fantony, Megan G Van Noord, 2018

机译：血红素素用于治疗尿路上的晚期或转移过渡性细胞癌：基于证据的安全性，疗效和治疗中的审查

Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety efficacy and place in therapy

摘要

著录项

相似文献

相关主题

期刊订阅